World Health Organization, WHO, has expressed concerns over counterfeit diabetes drugs currently in circulation since 2022. The organization stated that the problem is affecting all regions of the world.
This was contained in a statement, WHO referred specifically to findings in Britain, the U.S. and Brazil since October 2023.
It expressed concern over Ozempic, a medicine containing the active ingredient semaglutide. The drug is also approved in the EU for the treatment of type 2 diabetes.
However, WHO stated that the counterfeit version of Ozempic looks identical to the real medicine.
It stated that this because the product also suppresses the appetite. And it is increasingly being prescribed for weight loss.
WHO stated that counterfeit drugs may not contain the right amount of active ingredients. Therefore, they could lead to uncontrolled sugar in diabetics.
The organization also added that the drugs may also contain other active ingredients that pose health risks.
According to NAN, the WHO, therefore, called on doctors, pharmacists, regulatory authorities and the public to be vigilant.
“People should only buy medicines on prescription from pharmacies and not online,” WHO cautioned.
“Users should ensure that the dosage scale on insulin pens is displayed correctly. And that the label looks correct and there are no spelling mistakes on the box,” the statement said.
source: Daily Post
Follow us for more news on our WhatsApp News Channels @
https://whatsapp.com/channel/0029VaC505jB4hdZ5Yx9g82U